Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0164 | 1 | 0.5 |
Trichomonas vaginalis | macrophage migration inhibitory factor, mif, putative | 0.0164 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0164 | 1 | 0.5 |
Loa Loa (eye worm) | macrophage migration inhibitory factor | 0.0164 | 1 | 1 |
Giardia lamblia | Macrophage migration inhibitory factor | 0.0164 | 1 | 0.5 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0164 | 1 | 0.5 |
Plasmodium vivax | macrophage migration inhibitory factor, putative | 0.0164 | 1 | 0.5 |
Toxoplasma gondii | macrophage migration inhibitory factor, putative | 0.0164 | 1 | 0.5 |
Entamoeba histolytica | macrophage migration inhibitory factor-like protein | 0.0164 | 1 | 0.5 |
Plasmodium falciparum | macrophage migration inhibitory factor | 0.0164 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.